18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases
- PMID: 32088847
- PMCID: PMC7080035
- DOI: 10.1007/s00259-020-04734-w
18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases
Abstract
Purpose: The aim of this case series is to illustrate the 18F-FDG PET/CT findings of patients with acute respiratory disease caused by COVID-19 in Wuhan, Hubei province of China.
Methods: We describe the 18F-FDG PET/CT results from four patients who were admitted to the hospital with respiratory symptoms and fever between January 13 and January 20, 2020, when the COVID-19 outbreak was still unrecognized and the virus infectivity was unknown. A retrospective review of the patients' medical history, clinical and laboratory data, as well as imaging findings strongly suggested a diagnosis of COVID-19.
Results: All patients had peripheral ground-glass opacities and/or lung consolidations in more than two pulmonary lobes. Lung lesions were characterized by a high 18F-FDG uptake and there was evidence of lymph node involvement. Conversely, disseminated disease was absent, a finding suggesting that COVID-19 has pulmonary tropism.
Conclusions: Although 18F-FDG PET/CT cannot be routinely used in an emergency setting and is generally not recommended for infectious diseases, our pilot data shed light on the potential clinical utility of this imaging technique in the differential diagnosis of complex cases.
Keywords: 18F-FDG PET/CT; Acute respiratory disease; COVID-19; Consolidative opacities; Ground-glass opacities; Infection; SARS-CoV-2.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures




Comment in
-
18F-FDG PET/CT and COVID-19.Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1348. doi: 10.1007/s00259-020-04762-6. Epub 2020 Mar 12. Eur J Nucl Med Mol Imaging. 2020. PMID: 32166511 Free PMC article. No abstract available.
-
The potential added value of FDG PET/CT for COVID-19 pneumonia.Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1634-1635. doi: 10.1007/s00259-020-04767-1. Epub 2020 Mar 21. Eur J Nucl Med Mol Imaging. 2020. PMID: 32198615 Free PMC article. No abstract available.
-
PET imaging of COVID-19: the target and the number.Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1636-1637. doi: 10.1007/s00259-020-04820-z. Epub 2020 Apr 17. Eur J Nucl Med Mol Imaging. 2020. PMID: 32303786 Free PMC article. No abstract available.
-
The Use of Positron Emission Tomography in Coronavirus Disease 2019 Cases.J Thorac Oncol. 2020 Aug;15(8):e131. doi: 10.1016/j.jtho.2020.04.027. Epub 2020 May 5. J Thorac Oncol. 2020. PMID: 32387580 Free PMC article. No abstract available.
-
Added value of 18F-FDG PET/CT in a SARS-CoV-2-infected complex case with persistent fever.Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):2036-2037. doi: 10.1007/s00259-020-04860-5. Epub 2020 May 16. Eur J Nucl Med Mol Imaging. 2020. PMID: 32418065 Free PMC article. No abstract available.
-
COVID-19; beyond the obvious: how do we move forward?Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2070-2071. doi: 10.1007/s00259-020-04905-9. Epub 2020 Jun 11. Eur J Nucl Med Mol Imaging. 2020. PMID: 32529289 Free PMC article. No abstract available.
References
-
- Centers for Disease Control and Prevention. 2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary. January 28, 2020. https://www.cdc.gov/coronavirus/2019-nCoV/summary.html.
-
- Coronavirus latest: WHO officially names disease COVID-19. Nature News. February 11, 2020. https://www.nature.com/articles/d41586-020-00154-w.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous